[Clinical results of CDDP, MMC and 5-FU combination chemotherapy in advanced or recurrent gastrointestinal cancers]. 1987

T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
August 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
January 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
July 1986, Nihon Gan Chiryo Gakkai shi,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
November 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
October 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
January 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
June 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
March 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
January 1986, Auris, nasus, larynx,
T Sakuyama, and A Kimura, and S Yoshida, and S Yanagisawa, and K Soji, and H Hano, and N Takahashi, and F Nagao
February 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!